VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Reata Pharmaceuticals

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

  • Biotech & therapeutics
Open relationship map
Claim, correct or request removal

Record updated 22 September 2026

About

Reata was incubated in 2002 at UT Southwestern Medical Center in Dallas to develop therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases. In 2003, we invested in Reata, which was acquired by Biogen for $7.3 billion in 2023.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy